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Closure of the cranial neural tube depends on normal development of the head mesenchyme. Homozygous-mutant embryos for the ENU-
induced open mind (opm) mutation exhibit exencephaly associated with defects in head mesenchyme development and dorsal-lateral hinge point
formation. The head mesenchyme in opm mutant embryos is denser than in wildtype embryos and displays an abnormal cellular organization.
Since cells that originate from both the cephalic paraxial mesoderm and the neural crest populate the head mesenchyme, we explored the origin of
the abnormal head mesenchyme. opm mutant embryos show apparently normal development of neural crest-derived structures. Furthermore, the
abnormal head mesenchyme in opm mutant embryos is not derived from the neural crest, but instead expresses molecular markers of cephalic
mesoderm. We also report the identification of the opm mutation in the ubiquitously expressed Hectd1 E3 ubiquitin ligase. Two different Hectd1
alleles cause incompletely penetrant neural tube defects in heterozygous animals, indicating that Hectd1 function is required at a critical threshold
for neural tube closure. This low penetrance of neural tube defects in embryos heterozygous for Hectd1 mutations suggests that Hectd1 should be
considered as candidate susceptibility gene in human neural tube defects.
© 2007 Elsevier Inc. All rights reserved.Keywords: Neural tube closure; Neural tube defect; Head mesenchyme; Ubiquitin ligase; ENU mutagenesisIntroduction
The central nervous system of the vertebrate embryo
originates during gastrulation with the formation of the neural
plate. During subsequent development, the neural plate under-
goes extensive morphogenic movements resulting in formation
of the neural tube. When the neural tube fails to close
completely during its morphogenesis, neural tube defects result.
Neural tube defects are one of the most common human
congenital malformations occurring in approximately one out of
every one thousand live births (Copp et al., 2003; Zohn et al.,
2005). Common forms of neural tube defects include spina⁎ Corresponding author.
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doi:10.1016/j.ydbio.2007.03.018bifida and exencephaly where the neural tube remains open in
the most caudal and rostral aspects of the neural axis,
respectively. In humans, neural tube defects represent a
complex disease with multiple environmental and genetic
contributing factors. Because of the multifaceted etiology of
human neural tube defects, identification of causative mutations
has been problematic.
Vertebrate model systems have been indispensable for the
discovery of the processes required for neural tube closure. The
mouse has been particularly useful for identification of genes
required for proper morphogenesis of the neural tube and the
generation of numerous mouse models for neural tube defects
has implicated a long list of candidate genes for human neural
tube defects (Copp et al., 2003; Zohn et al., 2005). These genes
regulate cell movement, apoptosis, proliferation, patterning and
differentiation of not only the neural tissue, but also the
surrounding mesenchyme and non-neural ectoderm. Moreover,
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closure in mice has helped to uncover the genetic basis of neural
tube defects in humans (Gelineau-van Waes and Finnell, 2001).
Neural tube closure is a complex morphogenic process
where the neural plate rolls into a tube forming the central
nervous system (Copp et al., 2003; Zohn et al., 2005). The
neural folds form at the edges of the neural plate and rise
towards the dorsal midline due to forces from both the neural
tissue and the surrounding epithelium and mesenchyme. Apical
constriction of cells in the midline and in more lateral regions
results in the formation of medial and dorsal-lateral hinge points
respectively. In the cranial neural tube, neural fold elevation is
accompanied by an expansion of the head mesenchyme
(Morriss and Solursh, 1978) and reviewed in (Copp, 2005).
This expansion is mediated by both increased cell proliferation
and an increase in the extracellular space between the
mesenchymal cells and is thought to be critical to allow the
elevation of the neural folds. The molecular signals regulating
these cellular behaviors of the head mesenchyme remain
unknown.
Cells that originate from both the cephalic paraxial
mesoderm and the neural crest populate the head mesenchyme
(Noden and Trainor, 2005). The cephalic mesoderm is derived
from the cells in the primitive streak immediately caudal to the
node. As gastrulation progresses, cells from the paraxial
mesoderm spread medio-laterally from the primitive streak to
a position beneath the developing neural plate. In contrast, the
cranial neural crest is derived from cells that are located at the
junction of the neural and non-neural ectoderm. Once specified,
neural crest cells migrate ventral-laterally between the surface
ectoderm and the paraxial mesoderm. During later stages of
development, the paraxially-derived cephalic mesoderm con-
tributes to multiple structures such as the smooth and skeletal
muscles and some of the cartilaginous and bony elements of the
skull. The neural crest contributes to cranial nerves, blood
vessels and many of the bony elements of the head and face.
Cranial neural tube closure is critically dependent on the
proliferation and cellular rearrangement of the head mesench-
yme. Mouse models with deletions in the Twist1, Cart1 or
Tcfap2a genes exhibit cranial neural tube closure defects linked
to defects in development of the head mesenchyme (Chen and
Behringer, 1995; Schorle et al., 1996; Zhang et al., 1996; Zhao
et al., 1996). Twist1 function is required in the head
mesenchyme where it is expressed in both the paraxial
mesoderm and the neural crest lineages (Chen and Behringer,
1995). Yet it is unknown if either Twist1 or Cart1are required in
the mesoderm or neural crest or both lineages. Deletion of
Tcfap2a specifically in the neural crest results in exencephaly,
indicating that AP-2α function in the neural crest is essential for
cranial neural tube closure (Brewer et al., 2004).
Here we describe the further characterization of the neural
tube defects in the ENU-induced open mind (opm) mutant
mouse line. Homozygous opm mutant embryos exhibit severe
defects in cranial neural tube closure (Kasarskis et al., 1998).
We demonstrate that the neural tube closure defect in opm
mutant embryos is associated with a failure of dorsal-lateral
hinge point formation and an abnormal organization of the headmesenchyme surrounding the neural tube during closure. In
spite of the severe defects in cranial neural tube closure and the
abnormal head mesenchyme, opm mutant embryos exhibit
apparently normal development of neural crest-derived struc-
tures such as facial bones and palate. Neural crest development
also appears normal in opm mutant embryos as assayed by both
molecular marker and lineage-tracing analysis. In contrast,
analyses of the expression pattern of molecular markers that
mark the cephalic mesoderm suggest that this tissue is
abnormally dense in opm mutants. By positional cloning we
identify the opmmutation in an uncharacterized ubiquitin ligase
(Hectd1) that is ubiquitously expressed throughout early
development of the mouse embryo. Our data also indicate that
a critical threshold of Hectd1 function is required for neural tube
closure as up to 20% of mutant heterozygotes exhibit neural
tube defects depending on the mutant allele. The low penetrance
of neural tube defects in heterozygous embryos suggests that
Hectd1 should be considered as a candidate susceptibility gene
in human neural tube defects.Materials and methods
Analysis of mutant phenotype
Whole-mount and section RNA in situs were performed as described
(Holmes and Niswander, 2001; Liu et al., 1998) using the following probes:
Fgf8 (Crossley and Martin, 1995), BMP4 (Jones et al., 1991), Sox10 (Pusch
et al., 1998), AP-2α (Mitchell et al., 1991), Tbx1 (Chapman et al., 1996), Snail
(Nieto et al., 1992), Twist (Chen and Behringer, 1995), PDGFRα (Schatteman et
al., 1992). The expression pattern of Hectd1 was determined using an anti-sense
RNA probe synthesized from IMAGE clone: 3672615 or determining LacZ
activity inHectd1XC/+ embryos. For immunofluorescence experiments, embryos
were dissected from the decidua and fixed for 1 hour in 4% paraformaldehyde in
PBST (Phosphate-buffered saline (PBS) plus 0.1% Tween-20), washed 3 times
in PBST, cryopreserved in 30% sucrose in PBS, embedded in OCT compound
(Tissue-Tek) and sectioned at 10 μM. Fixed frozen sections were processed as
described (Timmer et al., 2002) using the anti-phospho-Histone H3 Mitosis
Marker (1:250; Upstate Biotechnology) for proliferation assays or the cleaved
Caspase-3 antibody (1:250; Cell Signaling #9661) for apoptosis assays. Sections
were mounted with Vectashield mounting medium with DAPI (Vector
Laboratories; H-1200) or stained with Hoechst (10 μg/ml; Sigma) to stain
nuclei and allow counts of the total number of cells. For Hematoxylin and Eosin
staining, embryos were fixed overnight in 4% paraformaldehyde in PBST and
processed for frozen sectioning as described (Timmer et al., 2002). Skeletal and
β-galactosidase staining were performed as described (Hogan et al., 1994).
Mouse strains and genotyping
The opm mouse line was identified in a screen for recessive ENU-induced
mutations that cause defects in neural tube closure at E9.5 (Garcia-Garcia et al.,
2005; Kasarskis et al., 1998; Zohn et al., 2005). The opm mutation was
generated on a C57BL/6J genetic background and backcrossed to C3H/HeJ for
at least 10 generations to obtain a congenic line. The mapping of the opm
mutation was done during the creation of the congenic line, while the high
resolution mapping data was generated once the congenic line (e.g. >N10) was
established. Approximately 5% of opm/+ embryos exhibit defects in cranial
neural tube closure (see Table 1). However, the neural tube defect in these
heterozygous embryos is less severe (only mid-and hindbrain exencephaly) and
can be easily distinguished at E9.5 and E10.5 from opm/opm embryos
(exencephaly from the forebrain to the hindbrain). For this reason, mapping of
the opmmutation was done using only E9.5 and E10.5 embryos from crosses of
opm/+ females mated to opm/+ males. In a mapping cross of 590 opportunities
for recombination, opm was mapped between the Massachusetts Institute of
Table 1
Mendelian ratios of opm/opm embryos are found upon dissection at E9.5–12.5
and a small percentage of opm/+ embryos exhibit exencephaly
Age Number of embryos
+/+ opm/
+
opm/
opm
Number of
embryos with
exencephaly
Number of
opm/+
embryos with
exencephaly
Total number
of embryos
E9.5 81 178 76 86 10 335
E10.5 50 83 43 45 2 176
E11.5 11 31 13 13 0 55
E12.5 4 9 9 11 3 22
Total 146 301 141 165 15 588
25% 51% 24% 28% 5%
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D12mit64 and D12mit54 with no recombination with D12mit110. For high-
resolution mapping, additional polymorphic DNA markers were generated
based on nucleotide repeat sequences and include: D12ski18, D12ski16 and
D12ski12 (see http://mouse.ski.mskcc.org/ for sequence of primers).
The entire Hectd1 transcript was sequenced by RT-PCR (Superscript One-
Step RT-PCR, Invitrogen) using RNA isolated from E10.5 opm/opm and
C57BL/6 control embryos. At position 430, a T to A transversion was
discovered in the 7833 base pair open reading frame that encodes Hectd1. This
mutation results in a nonsense mutation changing a Leucine to a stop codon at
amino acid 145 in the predicted 2611 amino acid Hectd1 protein.
A mouse embryonic stem (ES) cell line carrying an insertion in the Hectd1
gene (XC266) was identified from a blast search using the Hectd1-coding
sequence against the BayGenomics (http://baygenomics.ucsf.edu/) database
(Skarnes et al., 2004). Mice carrying the Hectd1 insertion were generated by
standard blastocyst injection followed by breeding for at least two generations
into a C3H background and named Hectd1XC. Mice carrying the genetrap allele
were genotyped using LacZ-specific primers (Liu et al., 1998). Other mouse
strains used were Wnt1-Cre (Danielian et al., 1998) and the R26R conditional
reporter allele (Soriano, 1999).
Results
opm mutant embryos exhibit exencephaly
In our ongoing ENU mutagenesis screens to identify genes
that are required for neural tube closure (Zohn et al., 2005), we
isolated the open mind (opm) mutant mouse line (Kasarskis et
al., 1998). This mouse mutant is distinct from the ENU-induced
openmind (om) mouse mutant, which harbors a mutation in the
Rere/atrophin-2 gene (Zoltewicz et al., 2004). As summarized
in Table 1, Mendelian ratios of opm/opm mutant embryos are
recovered with exencephaly upon dissection at E9.5-E12.5.
Additionally, approximately 5% of heterozygous embryos showFig. 1. opmmutant embryos exhibit defects in neural tube closure without other signif
and frontal (C, D, G, H, K and L) views of wildtype (A, C, E, G, I and K) and opm m
forebrain to the hindbrain and normal development of the face (A–D, E9.5; E–H, E10
E11.5 were labeled by in situ hybridization using probes against Fgf8 (G, H) and BMP
the neural crest as shown in coronal sections of E14.5 Wnt1–Cre/R26R wildtype (M
counterstained with eosin. Arrow points to the properly fused secondary palatal shelve
is abnormal in opmmutant embryos (P). The retinal pigmented epithelium (RPE, arro
in the head of opm mutant embryos. Profile (Q, R) and frontal (S, T) views of E17.5
development in spite of the severe neural tube closure defect. Lateral (U, V) and basal
Red in wildtype (U, W) and opmmutant (V, X) skulls. Asterisk (*) denotes exoccipita
point to frontal and pariatal bones that are malformed in opm mutant skulls.a less severe exencephaly affecting only the midbrain and
hindbrain (Table 1 and data not shown). Homozygous opm
mutant embryos display exencephaly characterized by a failure
of neural tube closure from the hindbrain to the forebrain. The
closure point at the most anterior aspect of the forebrain is
typically closed, but in some embryos this closure point remains
open resulting in a split of the facial primordia down the midline
at E9.5, although this appears to resolve as we do not detect
cranial-facial defects at later stages (Figs. 1A–L; see below and
data not shown (Kasarskis et al., 1998). Eye morphogenesis is
also affected as opm/opm mutant eyes are malformed, smaller
and are rotated in the head (Figs. 1O, P).
In spite of the severe defects in neural tube closure in opm
mutant embryos, other aspects of cranial-facial development
appear to be unaffected. The facial primordia consists of the
frontonasal prominence and the first branchial arch. Around
day 10, the nasal placodes in the frontonasal prominence
invaginate resulting in formation of the medial and lateral
nasal prominences (Kaufman and Bard, 1999). As shown in
Figs. 1G–H, Fgf8 is expressed in the ectoderm of the nasal
pits and the medial nasal process and is expressed in a similar
domain in both opm mutant and wildtype embryos. By E11.5,
the medial and lateral prominences fuse to form the nasal pits
as highlighted by Bmp4 expression (Fig. 1K). In the
developing face of opm mutant embryos, Bmp4 is expressed
in a similar domain as in wildtype (Fig. 1L). The secondary
palate forms from outgrowths of the medial walls of the
maxillary prominence, which fuse in the midline with the
nasal septum. Coronal sections of E14.5 wildtype and mutant
heads reveals that the secondary palatal shelves fuse normally
in opm mutant embryos (Figs. 1M, N). These results indicate
that unlike other mouse mutants which exhibit similar neural
tube closure defects from the forebrain to the hindbrain such
as Twist1, Cart1 or Tcfap2a (Chen and Behringer, 1995;
Schorle et al., 1996; Zhang et al., 1996; Zhao et al., 1996), the
facial primordia are able to undergo proper morphogenesis in
opm mutant embryos.
To further examine the effect of the opm mutation on
cranial-facial growth, development of the facial skeleton was
examined later in development (E17.5). As shown by the gross
morphology of the face of opm mutant embryos (Figs. 1Q–T),
the face and snout of mutant embryos develops normally.
Skeletal staining reveals that opm mutant embryos exhibit
some malformations in the growth of the skull vault such as
abnormally shaped frontal and parietal bones (arrowheads inicant defects in craniofacial development. Panels A–L: lateral (A, B, E, F, I and J)
utant (B, D, F, H, J, L) heads demonstrating neural tube closure defect from the
.5; I–L, E11.5). Frontal views of wildtype and opmmutant embryos at E10.5 and
4 (K, L) respectively to highlight the developing frontal nasal processes. Fate of
, O) and opm mutant (N, P) embryos stained for β-galactosidase activity and
s (PS; T=Tongue) in wildtype (M) and opmmutant (N) heads. Eye development
w), neural retina (NR) and lens appear histologically normal, but eyes are rotated
wildtype (Q, S) and opm mutant (R, T) heads demonstrating normal craniofacial
(W, X) views of E17.5 skeletal preparations stained with Alcian blue and Alizarin
l, petrosal and interpariatal bones that are missing in opmmutant skulls. Arrows
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interpariatal bones (* in Fig. 1V); however, these malforma-
tions are likely a secondary result of the cranial neural tube
closure defect (Copp, 2005). Aside from these malformations,
this analysis does not reveal any other gross morphologicaldefects in development of the cranial-facial skeleton (Figs.
1U–X). Therefore, unlike other mutants with similar neural
tube defects such as Twist, CART1 and Tcfap2a, craniofacial
development of structures rostral to the open neural tube is
normal in opm mutants.
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associated with defects in development of the head
mesenchyme
The failure of neural fold elevation and the open neural tube
from the forebrain to the hindbrain is strikingly similar to the
neural tube defects observed in CART1 and Twist mutant
embryos (Chen and Behringer, 1995; Zhao et al., 1996).
Previous studies have implicated the involvement of these
genes in proper development of the head mesenchyme. There-
fore, histological analysis was used to investigate whether the
head mesenchyme is affected in opm mutants. Coronal sections
of wildtype and opm mutant heads were stained with
hematoxylin and eosin to reveal the cellular organization of
the head mesenchyme surrounding the neural tube (Figs. 2A–
D). This analysis demonstrates that the head mesenchyme in
opm mutants is abnormal and appears to be denser around the
open neural tube (Figs. 2B, D). To further quantify the density of
the head mesenchyme cells, the number of head mesenchyme
cells in identical areas of wildtype and mutant heads in many
embryos were counted to obtain cell densities. Since an
increased cell density could result from a failure of neural fold
elevation, areas of headmesenchymewere selected ventral to the
dorsal-lateral hinge points such as those in the boxed regions of
Figs. 2A and C. The density of cells in the head mesenchyme of
E9.5 mutant embryos were significantly (p<0.0001) greater
than in wildtype embryos as determined by the Mann-Whitney
U test (Figs. 2I). Furthermore, the increased cell density is
observed early as the neural folds are beginning to elevate (e.g. at
E8.5). This is in contrast to our earlier findings suggesting that
the mesenchyme was less dense (Kasarskis et al., 1998). After
our current careful analysis, our previous observation now
appears to be an artifact of the plane of few sagittal sections. We
also observed an increase in the thickness of the head
mesenchyme around the dorsal and lateral aspects of the neural
tube in mutant versus wildtype embryos (Figs. 2A, C, E, F
brackets). This expansion of head mesenchyme is not seen in
other mouse mutant lines with exencephaly from our screens.
For example, neural tube defects in the humdy mutant mouse
line are associated with an increase in the proliferation of neural
tissue (Tae-Hee Kim and Lee Niswander, submitted). Further-
more, the head mesenchyme is not denser in humdy mutants
indicating that abnormal head mesenchyme is not always
secondary to failure of neural tube closure. These findings
indicate that the opm phenotype is associated with an abnormal
organization of the head mesenchyme around the cranial neural
tube.
In order to determine if the abnormal organization of head
mesenchyme in opm mutant embryos occurs before cranial
neural tube closure, the head mesenchyme was examined at a
stage that precedes this event. Coronal sections of embryos at
E8.5 (12 somites; Figs. 2G, H) were stained with Hoechst to
highlight the morphology of the tissue. As indicated by brackets
in Figs. 2G, H, these defects precede cranial neural tube closure
as the thickness of the head mesenchyme around the neural tube
is already increased at this stage. Additionally, quantification of
cell density in the head mesenchyme of E8.5 embryos indicatesthat there is a significant difference (p<0.0001; Mann-Whitney
U test) between the density of cells in wildtype and mutant
embryos even before neural tube closure (Fig. 2I). Since, the
increase in cell density precedes neural tube closure, it is
unlikely due to the failure of neural tube closure. Taken together,
these results suggest that the neural tube defect in opm mutant
embryos could be due (at least in part) to the abnormal
organization and increased density of the head mesenchyme
surrounding the neural tube during neural fold elevation and
neural tube closure.
Another mechanistic defect that can lead to neural tube
defects is a failure to form the hinge points, which facilitate
the convergence of the neural folds in the dorsal midline. The
medial hinge point forms normally in opm mutant embryos
(Figs. 2A–H), consistent with normal dorsal-ventral patterning
of the neural tissue (data not shown), both processes which are
known to be regulated by Shh signaling (Caspary and
Anderson, 2003; Ybot-Gonzalez et al., 2002). In contrast,
the dorsal-lateral hinge points completely fail to form in opm
mutants (arrows; Figs. 2A–H), resulting in a flat or convex
curvature of the neural tissue rather than the concave and
closed neural tube seen in wildtype embryos (Figs. 1C, D and
2A–F).
To determine if the dense head mesenchyme results from
changes in cell proliferation or apoptosis, these processes were
examined in E8.5 and E9.5 embryos, prior to and during the
time of cranial neural closure. Apoptosis was examined using
the cleaved caspase-3 antibody, which marks cells that are
initiating apoptosis. In wildtype and mutant embryos, very few
cells were undergoing apoptosis in the head mesenchyme
surrounding the neural tube (data not shown). Therefore it is
unlikely that differences in apoptosis are responsible for the
dramatic differences in the number of cells populating the head
mesenchyme of wildtype and opm mutant embryos. Prolifera-
tion was measured by examining expression of phosphorylated-
Histone-3 (P-H3), which increases during mitosis. To assess the
rate of proliferation, the number of P-H3 positive cells were
counted and divided by the number of cells in a given area of the
head mesenchyme to give a mitotic index as shown in Fig. 2J.
To determine if mitotic indexes are significantly different in
opm mutant versus wildtype head mesenchyme, the Mann-
Whitney U test was used. For E8.5 and E9.5 wildtype versus
opm mutants the p-value was 0.1980 and 0.9552, respectively.
These results indicate that there are no significant differences in
the mitotic indexes of the abnormal head mesenchyme
surrounding the neural tube in opm mutant embryos as
compared to control littermates.
opm mutant embryos do not exhibit defects in neural crest cell
development
Our data indicate that neural tube defects in opm mutant
embryos are associated with defects in development of the head
mesenchyme. Additionally, the open neural tube phenotype of
opm mutants is reminiscent of the neural tube defects exhibited
by Twist and Tcfap2a mutants (Chen and Behringer, 1995;
Schorle et al., 1996; Zhang et al., 1996; Zhao et al., 1996),
Fig. 2. Abnormal head mesenchyme development in opm mutant embryos is associated with neural tube closure defects. (A–D). Hematoxylin and Eosin (H and E)
staining of coronal sections of wildtype (A, B) and opmmutant (C, D) heads at E9.5. Brackets highlight the region of head mesenchyme that are expanded around the
opm neural tube. Panels B and D show magnified views of the boxes drawn in panels A and C, demonstrating the abnormally dense cellular organization of opm
mutant head mesenchyme. (E–H). Nuclei were visualized by staining with Hoechst in coronal sections of wildtype (E, G) and opm mutant (F, H) at E9.5 (E, F) and
E8.5 (G, H) demonstrating that the head mesenchyme is denser around the dorsal neural tube of opm mutant embryos during neurulation. There is also a failure of
dorsal-lateral hinge point formation leading to a flat or convex curvature of the opm neural tube compared to the concave neural tube in wildtype embryos at both
stages. Arrows point to dorsal-lateral hinge points in panels A–H. (I) Cell density was determined by counting the number of nuclei in 1–2 defined areas on many
sections from many embryos (E9.5: wildtype n=39 areas, opm mutant n=41 areas; E8.5: wildtype n=58 areas, opm mutant n=63 areas). Error bars represent one
standard deviation from the mean. The density of cells between wildtype and opmmutant samples are significantly different as calculated by the Mann-Whitney U test
(E9.5: P-value<0.0001*; E8.5: P-value<0.0001*). (J) Mitotic indexes were calculated by dividing the number of P-H3 positive cells by the number of nuclei in a
given area for wildtype and opmmutant in two to three sections from many embryos (E9.5: wildtype n=19 sections, opmmutant n=20 sections; E8.5: wildtype n=17
sections, opm mutant n=18 sections). Error bars represent one standard deviation from the mean. Samples are not significantly different as calculated by the Mann-
Whitney U test (E9.5: P-value=0.9552; E8.5: P-value=0.1980).
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mesenchyme. Since the head mesenchyme is composed of cells
that are of both neural crest and mesoderm origin (Noden and
Trainor, 2005), the head mesenchyme defect in opm mutant
embryos could originate from either source. Therefore, we
sought to determine the origin of the abnormal head
mesenchyme using a molecular marker analysis. If the abnormal
head mesenchyme is due to defects in neural crest cell
development, this should be evident by examination of neural
crest specific markers at early developmental stages. Examina-tion of Sox10 and AP-2α expression at E8.5 indicated that
neural crest induction and its initial migration are normal in
opm mutant embryos (Figs. 3A–D). Additionally, expression
of Sox10 and AP-2α at E9.5 indicates that the neural crest
migrates and undergoes its initial differentiation normally (Figs.
3E-H). Lastly, the expression of AP-2α at E9.5 indicates that the
neural crest does not contribute to the regions of abnormal
mesenchyme of opm mutants (* in Fig. 3H). This normal initial
development of neural crest derived structures in opm mutant
embryos agrees with our observations that later in development,
Fig. 3. Neural crest cell development is normal in opm mutant heads. E8.5 (A–D) and E9.5 (F–H) wildtype (A, C, E, G) and opm mutant (B, D, F, H) embryos were
analyzed by whole-mount in situ hybridization analysis for expression of Sox10 (A, B, E, F) and AP-2α (C, D, G, H). Asterisk (*) in panel H denotes the lack of AP-2α
expression in the abnormal head mesenchyme surrounding the open neural tube in the opm mutant head. V, VII/VIII and IX denote the Sox10-expressing cranial
nerves. OV=otic vesicle. Fate of the neural crest in E9.5 Wnt1-Cre/R26R wildtype (I) and opm mutant (J) embryos that were stained in whole-mount for β-
galactosidase activity. Asterisk (*) highlights the abnormal head mesenchyme in opmmutant embryos that is negative for β-galactosidase activity. Coronal sections of
E9.5 Wnt1-Cre/R26R wildtype (K) and opm mutant (L) head stained for β-galactosidase and counterstained with eosin. Brackets highlight the abnormally expanded
head mesenchyme in opm mutant embryos that is negative for β-galactosidase activity.
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palate develop normally in opm mutants (Figs. 1M–X).
To further explore a potential contribution of neural crest
cells to the abnormal head mesenchyme in opm mutants,
genetic fate-mapping experiments were performed. For these
experiments, the opm mutation was crossed into the Wnt1-Cre
and R26R transgenic mouse strains (Danielian et al., 1998;
Soriano, 1999). As shown in Figs. 3I, J, E9.5 opm mutant
embryos exhibit normal development of Wnt1-lineage traced
cells in the head mesenchyme. In fact, the abnormally dense
tissue surrounding the neural tube in opm mutant embryos is
LacZ-negative (* in Fig. 3J). This is better visualized in
coronal sections where it is evident that cells of neural crest
origin do not populate the abnormal head mesenchyme
surrounding the open neural tube and migrate to the correct
position in the developing heads of opm mutant embryos (Figs.
3K, L). Thus, this lineage tracing experiment clearly indicates that
the abnormal head mesenchyme is not of neural crest origin
(brackets in Figs. 3K, L).Molecular markers of cephalic mesoderm
The results described above indicate that the abnormal head
mesenchyme surrounding the open neural tube in opm mutants
is not derived from the neural crest. Therefore, we next sought
to determine if this head mesenchyme is derived from the
cephalic mesoderm. To do so, the expression of a number of
molecular markers of cephalic mesoderm was examined. Tbx1
is expressed in the caudal cephalic mesoderm and the mesoderm
that populates the branchial arches. Examination of Tbx1 in
wildtype and opm mutant embryos at E9.5 and E8.5 indicates
that its expression domain is not expanded in opm mutant
embryos (Figs. 4A–D). In contrast, in situ hybridization
analysis at E9.5 using antisense probes against Snail, Twist
and PDGFRα, molecular markers of both cranial neural crest
and mesoderm, indicates that the abnormal head mesenchyme
in opm mutant embryos expresses these markers (Figs. 4E–J).
Since the head mesenchyme is partially obscured by exence-
phalic neural tissue in the whole mount in situs, expression of
Fig. 4. The abnormal head mesenchyme in opmmutant embryos expresses molecular markers of cephalic mesoderm. E9.5 (A, B, E–J) and E8.5 (C, D, O–R) wildtype
(A, C, E, G, I, O, Q) and opmmutant (B, D, F, H, J, P, R) heads were analyzed by whole-mount in situ hybridization analysis for expression of Tbx1 (A–D), Snail (E, F,
O, P), Twist (G, H, Q, R) and PDGFRα (I, J). Asterisk (*) denotes staining in the abnormal head mesenchyme surrounding the open neural tube in opm mutant
embryos. Coronal sections of wildtype (K, M) and opm mutant (L, N) heads stained by in situ hybridization for expression of Twist (K, L) and PDGFRα (M, N).
Brackets highlight the abnormal head mesenchyme surrounding the open neural tube in opm mutant embryos.
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Examination of section in situs clearly shows that the
expression domain of both Twist and PDGFRα is expanded in
opm mutant heads (Figs. 4K–N). This is not simply due to
the exencephaly, as mouse mutants that have exencephaly
associated with, for example, defects in the organization of
actin in the neural tissue do not show this expansion of Twist
surrounding the neural tube (Hildebrand and Soriano, 1999). At
E8.5, the expression of Snail in the abnormal head mesench-
yme in opm mutant embryos is less evident. However, Twist
appears to be expressed in an expanded domain at this stage(Figs. 4O–R, *). These results combined with our analysis of
neural crest cell fate indicates that the abnormal head mesen-
chyme associated with the cranial neural tube closure defects in
opm mutant embryos is derived from the cephalic mesoderm
rather than the neural crest and that this defect occurs as early as
E8.5.
The opm mutation disrupts a HECT domain ubiquitin ligase
Using positional cloning techniques, the opm mutation was
mapped to a 1.7 MB interval on mouse chromosome 12 that
216 I.E. Zohn et al. / Developmental Biology 306 (2007) 208–221contains 12 genes (Fig. 5A). One interesting candidate was a
novel ubiquitin ligase (Hectd1) with a Hect-domain (Homolo-
gous to E6-AP Carboxy Terminal). Hect-domain ubiquitin
ligases mediate transfer of ubiquitin and target substrate
proteins for either degradation or modification of activity
(Kerscher et al., 2006). Upon sequencing, a point mutation wasFig. 5. The opm mutation disrupts the uncharacterized Hectd1 ubiquitin ligase. (
recombination events over the number of opportunities for recombination is indic
separated from the opm phenotype. Within this interval are twelve transcription units
gene), Scfd1(sec1 family domain containing 1), Coch(coagulation factor C homolo
complex AP-4, sigma 1), Hectd1 (HECT domain containing 1), Q8CCC9 (PREDICT
6530401N04Rik (RIKEN cDNA 6530401N04 gene), Gpr33(G protein-coupled recep
interval and physical map position (mb) is from the Ensemble mouse genome as
transversion (green arrow) at position 430 in theHectd1 coding sequence. This mutati
Hectd1XC gene trap allele fails to complement Hectd1opm as embryos at E9.5 exhibit
(C, E) and frontal (D, F) views of wildtype (C, D) and Hectd1opm/XC mutant (E, F) E9
MIB-HERC2 domain (mib) and a C-terminal Homologous to the E6-AP Carboxyl Te
amino acid 145. The Hectd1XC mutation results in an insertion and truncation of theidentified in the Hectd1 gene (Fig. 5B). The mutation results in
a T to A transversion and a change of a Leucine to a stop codon
after amino acid 144 in the predicted 2611 amino acid Hectd1
protein (predicted molecular weight of 289 KD). The Hectd1
protein contains a number of conserved protein domains (Fig.
5G): an ankyrin repeat in the N-terminal portion of the proteinA) Genetic map of opm interval on mouse chromosome 12. The number of
ated for each polymorphic marker. Markers D12ski16 and D12MIT110 never
: Rps11 (ribosomal protein S11), 6030308C04RIK (RIKEN cDNA 6030408C04
g), Strn3(striatin, calmodulin binding protein 3), Ap4s1(adaptor-related protein
ED: hypothetical protein), D930036F22Rik (RIKEN cDNA D930036F22 gene),
tor 33) and Nubp1 (nucleotide binding protein-like). The transcripts in the opm
sembly release #40. (B) The opm ENU-induced mutation results in a T to A
on results in a nonsense mutation changing a Leucine to a stop codon. (C–F) The
exencephaly from the hindbrain to the forebrain (E, F). Panels C–F show lateral
.5 embryos. (G) Predicted protein motifs in Hectd1: an ankyrin domain (ANK),
rminus domain (HECT). The Hectd1opmmutation results in a truncated protein at
HECT domain.
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bomb (mib) domain and a C-terminal HECT domain. These
domains are also present in a number of E3 ubiquitin ligases.
The opm mutation results in truncation of the Hectd1 protein
before any of these conserved domains and likely represents a
null allele (Fig. 5G).
To confirm that this mutation in Hectd1 is responsible for
the developmental defects observed in the opm mutant line, a
second allele was obtained from the BayGenomics genetrap
resource (Skarnes et al., 2004). The genetrap allele, Hectd1XC,
consists of a LacZ-Stop cassette inserted into the HECT
domain (Fig. 5G). A complementation test was done to
confirm that the Hectd1 mutation in the opm mouse line is
responsible for the observed phenotypes. Embryos were
generated that consist of the genetrap allele over the opm
allele (Hectd1XC/opm) and the phenotype in mutant embryos
was examined at E9.5. Hectd1XC/opm embryos exhibit exen-
cephaly that is identical to that observed in opm homozygous
mutant embryos (Figs. 5C–F). Moreover, the phenotype of
Hectd1XC/XC mutant embryos was identical to that of Hectd1-
mutants (data not shown and Table 2). Interestingly, embryos
heterozygous for the Hectd1XC allele exhibited exencephaly at
a much higher frequency (8/40=20% of embryos) than
Hectd1opm/+ embryos, which exhibit exencephaly in only 5%
of cases, indicating a weak dominant-negative effect of the
Hectd1XC allele (compare Tables 1 and 2). These results
confirm that the point mutation identified in the Hectd1 gene is
responsible for the phenotypes observed in opm mutants.
Furthermore, the observation that disruption of the HECT
domain produces the same neural tube closure defect
phenotype as the null allele indicates that the ubiquitin ligase
activity of Hectd1 is essential for its biological function.
Expression of the opm gene during embryogenesis
We examined the expression pattern of Hectd1 during
neurulation in Hectd1XC embryos that expresses the βgeo
reporter under the endogenous Hectd1 promoter. In phenoty-
pically normal Hectd1XC/+ embryos, Hectd1:βgeo was
expressed ubiquitously during gastrulation and neurulation
(Fig. 6). Importantly, LacZ activity was detected in the
developing head mesenchyme, consistent with a role for
Hectd1 in development of this tissue (Figs. 6C–F). Addition-Table 2
Hectd1XC/+ embryos exhibit exencephaly at a higher frequency than Hecd1opm/+
embryos
Age Number of embryos
+/+ XC/+ XC/XC Number of
embryos with
exencephaly
Number of XC/+
embryos with
exencephaly
Total
number of
embryos
E9.5 9 22 14 18 4 45
E10.5 1 5 0 1 1 6
E11.5 2 10 5 8 3 17
E12.5 2 3 2 2 0 7
Total 17 40 22 30 8 79
22% 50% 28% 38% 20%ally, LacZ activity was detected in the placenta (Fig. 6G), and at
higher levels in other developing tissues such as the lens of the
eye (Fig. 6H), the differentiated neurons in the spinal neural
tube (Fig. 6I) and the atrium of the heart (Fig. 6J).
Discussion
Neural tube closure defects are common developmental
malformations that result in death or long-term physical
disabilities in humans. Here we show that an ENU-induced
mutation in the open mind (opm) mutant mouse line disrupts the
gene encoding the uncharacterized Hectd1 ubiquitin ligase. The
cranial neural tube of opm mutant embryos fails to undergo
proper morphogenesis and is open from the forebrain to the
hindbrain. This neural tube defect is accompanied by an
increase in the density and abnormal organization of the head
mesenchyme surrounding the open neural tube, as well as
failure to form the dorsal-lateral hinge points. Neural crest
development in opm mutant embryos is apparently normal as
determined by development of neural crest-derived structures.
Additionally, molecular marker and lineage-tracing analysis
during the induction and migration of the neural crest indicates
that these processes occur normally in opmmutants. In contrast,
the abnormal head mesenchyme expresses molecular markers of
cephalic mesoderm indicating that Hectd1 is required for
normal development of this lineage. Finally, the low penetrance
of neural tube defects in Hectd1 mutant heterozygotes indicates
that the level of Hectd1 gene activity is critical for proper
closure of the neural tube.
Mechanism of cranial neural tube closure defects in opm
mutant embryos
During cranial neural tube closure, the head mesenchyme
undergoes expansion by increasing both cell proliferation and
the extracellular space between mesenchymal cells (Morriss and
Solursh, 1978). This expansion is thought to be required for
elevation of the neural folds (Copp, 2005; Copp et al., 2003).
Neural fold elevation is also mediated by bending of the
neuroepithelium through apical constriction resulting in the
formation of the medial and dorsal-lateral hinge points (Copp,
2005; Copp et al., 2003). Together these forces convert the flat
neural plate to a concave morphology contributing to the
convergence of the neural folds in the dorsal midline and their
subsequent fusion. The cranial neural tube in opm mutant
embryos exhibits a complete failure of dorsal-lateral hinge point
formation and neural fold elevation. Furthermore, expanded and
denser head mesenchyme around the cranial neural tube during
closure accompanies this failure in neural fold elevation.
Genetic evidence that cranial neural tube closure is
dependent on the proper expansion of the head mesenchyme
is supported by studies of the Twist and CART1 mutant
phenotypes (Chen and Behringer, 1995; Zhao et al., 1996). Like
opmmutant embryos, Twist and CART1mutants exhibit failures
of cranial neural fold elevation. However, rather than the
increased density of head mesenchyme observed in opm mutant
embryos, Twist and CART1 mutants exhibit a decrease in the
Fig. 6. Hectd1 is ubiquitously expressed during development of the mouse embryo.Hectd1 expression was monitored by staining for β-galactosidase activity in whole
mount (A, C, D) or in section and counterstained with eosin (B, E–J) in Hectd1XC/+ embryos. Hectd1 is expressed during development of the head mesenchyme at
E7.5 (A, B), E8.5 (C–E) E9.5 (F). Hectd1 is also expressed in the placenta (G) and eye (H) at E12.5. Hectd1 is expressed at E11.5 at higher levels in differentiated
neurons of the developing spinal cord (I) and the atrium of the heart (J).
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proliferation and increased apoptosis, respectively (Chen and
Behringer, 1995; Zhao et al., 1996). In contrast, our data do not
indicate a statistically significant change in proliferation or
apoptosis of the head mesenchyme during neurulation in opm
mutants. Furthermore, we show through both lineage tracing
and molecular marker analysis that the abnormal head
mesenchyme is not derived from the cranial neural crest but
instead from the cephalic mesoderm. Below we suggest
possible molecular and cellular mechanisms by which loss of
Hectd1 ubiquitin ligase function could lead to the increased
density of the cephalic mesoderm observed in opm mutant
embryos. Together these data indicate that neural fold elevation
requires that the amount of head mesenchyme be carefullybalanced; either too much (opm mutants) or too little (Twist and
CART1 mutants) head mesenchyme can lead to a failure of
neural fold elevation and neural tube closure.
opm mutant embryos also display a lack of dorsal-lateral
hinge point formation in the cranial neural tube, although
formation of the medial hinge point appears normal. With
respect to the cranial neural tube, it is known that dorsal-lateral
hinge point formation is essential for neural fold elevation;
however the mechanisms that regulate dorsal-lateral hinge point
formation are unknown. Some potential mechanisms could be
extrapolated from our knowledge of dorsal-lateral hinge point
formation in the spinal neural tube; however, these mechanisms
have not been determined experimentally for cranial neurulation.
In the spinal neural tube there are two described mechanisms
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First, Shh signaling inhibits formation of the dorsal-lateral
hinge points (Ybot-Gonzalez et al., 2002). In the anterior
regions of the spinal neural tube, dorsal-lateral hinge point
formation is inhibited by robust Shh signals from the notochord
and floorplate. In contrast, in the more caudal regions of the
spinal neural tube, Shh signals from the notochord and
floorplate diminish allowing the formation of dorsal-lateral
hinge points. Failure of this mechanism does not likely play a
role in opm mutants as our data indicate that there are no
obvious changes in dorsal-ventral patterning of the anterior
neural tissue in opm mutants (data not shown), consistent with
normal levels of Shh signaling. Second, in the spinal neural
tube, contact with the surface ectoderm is required for induction
of the dorsal-lateral hinge points (Hackett et al., 1997). If this
mechanism also plays a role in induction of the dorsal-lateral
hinge points in the cranial neural tube, then it is possible that the
overexpansion of head mesenchyme in opm mutant embryos
around the neural tube could interfere with this inductive
interaction. Indeed, in opm mutants the surface ectoderm is
greatly separated from the cranial neural tube (Fig. 2),
suggesting that contact between these two tissues could be
required for dorsal-lateral hinge point formation in the cranial
regions of the neural tube. Alternatively, it is possible that the
denser head mesenchyme simply causes mechanical inhibition
of neural fold elevation.
While we detected a defect in the development of the
head mesenchyme associated with cranial neural tube closure
defects in opm mutant embryos, it is still a distinct possibility
that Hectd1 is also required in other cell lineages for neural
tube closure. Our analysis of the expression of Hectd1
indicates that the transcript is also expressed in the neural
and non-neural ectoderm during neural tube closure. There-
fore, further experiments such as tissue specific deletion of
Hectd1 or chimeric analysis are needed to determine if
expression of Hectd1 in these tissues also contributes to the
lack of dorsal-lateral hinge point formation and the
subsequent failure to close the cranial neural tube in opm
mutant embryos.
Ubiquitination and regulation of development
In recent years, the importance of posttranslational
modification of proteins by ubiquitin during embryonic
development has become increasingly apparent. Ubiquitina-
tion results in the conjugation of a 76 amino acid polypeptide
(ubiquitin) to substrate proteins (Kerscher et al., 2006).
Polyubiquitination targets proteins for destruction in the
proteasome, while monoubiquitination results in the modifi-
cation of protein function and/or processing. Ubiquitination is
a multistep process where an Ubiquitin-activating enzyme
(E1) activates ubiquitin and transfers it to an ubiquitin-
conjugating enzyme (E2). The E3 ubiquitin ligase associates
with both the E2 enzyme and the target substrate through
protein-protein interaction domains. There are two main types
of ubiquitin ligases: ones that contain a Ring domain and
ones that contain a C-terminal HECT (homologous to E6-APcarboxy terminal) domain, the latter type includes Hectd1.
The substrate specificity of the ubiquitin pathway arises
from the interaction of the E3 ligases with their substrates
and the HECT domain ligases typically interact directly with
their substrates.
The opm mutation occurs in a gene encoding a novel E3
ubiquitin ligase, Hectd1. Gene identification was confirmed by
failure of complementation with the genetrap allele (Hectd1XC)
in which the HECT domain was disrupted. Additionally, the
identical phenotypes observed in mutant embryos homozygous
for the Hectd1opm (presumed null) and Hecd1XC alleles indicate
that ubiquitin ligase activity is essential for the function of
Hectd1 in vivo. The observation that mutation of Hectd1 results
in the opm phenotype suggests that posttranslational modifica-
tion of an unknown substrate protein(s) is required for normal
development of the head mesenchyme. Since we find that the
head mesenchyme around the neural tube is denser as early as
E8.5, and that no significant difference in proliferation rates in
the head mesenchyme are observed between wildtype and
mutant embryos at this stage, expansion of the head mesen–
chyme could be due to misregulation of the numbers of pro-
genitor cells specified in the primitive streak, the origin of the
cephalic mesoderm. As an example, it is possible that Hectd1
normally regulates a pathway that is required for patterning of
the primitive streak, for instance by regulating the strength and/
or duration of a patterning signal. Therefore, in this situation,
loss of ubiquitin modification by Hectd1 in opm mutants could
result in abnormal signaling and an increase in the number of
cephalic mesoderm precursors set aside in the primitive streak.
Alternatively, it is possible that the apparent expansion of the
head mesenchyme is due to a failure to reorganize during
neural tube closure. Since the increased density of head
mesenchyme indicates that the extracellular space between the
mesenchymal cells is also not increased appropriately, it is
possible that Hectd1 could regulate the quantity or quality of
the extracellular matrix required for reorganization of the head
mesenchyme.
Determination of the substrate(s) of the Hectd1 ubiquitin
ligase will also lead to a greater understanding of the
mechanisms underlying the neural tube closure defects in opm
mutants. Currently the substrate(s) of Hectd1 are unknown;
however, the human orthologue of Hectd1, KIAA1131 was
recently identified in yeast two-hybrid screens (Nakayama et al.,
2002) and (NCBI accession: AAP13073). In both of these
screens, Hectd1 was found to bind Immunoglobulin-like
domain containing 1 protein (Igsf1), implicating Igsf1 as a
potential Hectd1 substrate. Originally, Igsf1 was identified in a
screen for proteins that bound the TGFβ antagonist Inhibin and
was thus also named InhBP/p120 (Chong et al., 2000);
however, subsequent studies have questioned the ability of
InhBP/p120 to modulate Inhibin signaling (Bernard et al., 2003;
Chapman et al., 2002). The future identification of Hectd1
substrates and their modification by ubiquitination will increase
our understanding of the molecular pathways that regulate the
normal (and abnormal) development of the cephalic mesoderm
and neural tube closure and provide further molecular insight
into the etiology of the opm phenotype.
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heterozygotes suggests a candidate susceptibility gene locus
Embryos heterozygous for the opm allele (presumed null)
display a low frequency (∼5%) neural tube defects. This sug-
gests that the level of Hectd1 function is critical and that loss of
one allele can decrease protein function below a critical thres-
hold. Interestingly, embryos heterozygous for the gene trap allele
(Hectd1XC) in which the C-terminal HECT domain is disrupted
display a higher frequency (∼20%) of neural tube defects. It has
been shown that mutation of a conserved cysteine in the HECT
domain results in a dominant-negative protein by maintaining
the interaction of the ligase with the substrate but preventing
ubiquitination (Huibregtse et al., 1995; Talis et al., 1998). Thus,
the Hectd1XC allele could create a dominant-negative protein
that prevents interaction of the wildtype protein with the
substrate, potentially explaining the higher frequency of neural
tube defects in the XC heterozygotes relative to the opm allele.
Neural tube closure defects are one of the most common
birth defects in humans with approximately one in one thousand
live births affected. It is likely that in some cases the genetic
factors contributing to human neural tube defects result from a
low penetrance of neural tube defects in heterozygous
individuals with null or dominant negative mutations in genes
that are required for neural tube closure (Harris and Juriloff,
2006). Therefore, it is of interest that Hectd1 heterozygotes
display variable expressivity of neural tube defects in hetero-
zygous individuals. Our observations that Hectd1 function is
required at a critical threshold level suggest Hectd1 would be a
good candidate for a susceptibility gene contributing to neural
tube closure defects in humans.
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